Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,724 public trials 629 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD.

NCT00452400

Conditions
Asthma, Bronchial Diseases, Chronic Disease, +11 more
Locations
  • 1222.5.03 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • 1222.5.07 Boehringer Ingelheim Investigational Site Lakewood, California, United States
  • 1222.5.14 Boehringer Ingelheim Investigational Site Denver, Colorado, United States
  • 1222.5.13 Boehringer Ingelheim Investigational Site Wheat Ridge, Colorado, United States
View all 42 locations
View Trial Details
Completed

AZISAST Study: AZIthromycin in Severe ASThma Study

NCT00760838

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Onze Lieve Vrouw Ziekenhuis Aalst Aalst, Belgium
  • ZNA Middelheim Antwerp, Belgium
  • AZ Sint-Jan Brugge Bruges, Belgium
  • Ghent University Hospital Ghent, Belgium
View Trial Details
Completed

Biomarkers of Cockroach Sublingual Immunotherapy 2

NCT01380327

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +12 more
Locations
  • Children's Memorial Hospital Chicago, Illinois, United States
  • Johns Hopkins University School of Medicine Baltimore, Maryland, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Cincinnati Children's Hospital Cincinnati, Ohio, United States
View Trial Details
Completed

Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma I

NCT01172808

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • 205.418.01020 Boehringer Ingelheim Investigational Site Huntington Beach, California, United States
  • 205.418.01002 Boehringer Ingelheim Investigational Site Mission Viejo, California, United States
  • 205.418.01014 Boehringer Ingelheim Investigational Site San Diego, California, United States
  • 205.418.01011 Boehringer Ingelheim Investigational Site Wheat Ridge, Colorado, United States
View all 114 locations
View Trial Details
Completed

Patient Registry Study of Berinert® in Normal Clinical Practice

NCT01108848

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +14 more
Locations
  • United States, Arizona Scottsdale, Arizona, United States
  • United States, California Granada Hills, California, United States
  • United States, California Los Angeles, California, United States
  • United States, California Redding, California, United States
View all 40 locations
View Trial Details
Completed

Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma II

NCT01172821

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • 205.419.01058 Boehringer Ingelheim Investigational Site Los Angeles, California, United States
  • 205.419.01053 Boehringer Ingelheim Investigational Site Stockton, California, United States
  • 205.419.01061 Boehringer Ingelheim Investigational Site Centennial, Colorado, United States
  • 205.419.01066 Boehringer Ingelheim Investigational Site Denver, Colorado, United States
View all 125 locations
View Trial Details
Completed

Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma

NCT00317044

Conditions
Asthma, Bronchial Diseases, Deglutition Disorders, +13 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Scottsdale, Arizona, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site Fountain Valley, California, United States
View all 130 locations
View Trial Details

Related conditions